Articles From: Manhattan Condo Inventory Shows Largest Annual Increase in Nearly Five Years, But Boost Doesn't Shake Record-High Sale Prices to MasterCard Works with Apple to Integrate Apple Pay


2014/8/29
Condo sale prices reach 19-year high according to the StreetEasy Condo Price Index NEW YORK , Aug.
Sign-up for Manhattan Condo Inventory Shows Largest Annual Increase in Nearly Five Years, But Boost Doesn't Shake Record-High Sale Prices investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0971849001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg http://media3.marketwire.com/logos/20141007-argus1007.jpg TORONTO, ONTARIO and MELBOURNE, AUSTRALIA --
Sign-up for ARGUS Enterprise Goes Global investment picks
2014/9/22
Broadway Financial Corporation (the “Company”) (NASDAQ Capital Market: BYFC), announced that on Thursday September 18 th , its wholly-owned subsidiary, Broadway Federal Bank, f.s.b. (the “Bank”), received a Bank Enterprise Award (“BEA”) of $355,000 for providing Affordable Housing Development Loans and Project Investments and Service Activities in California.
Sign-up for Broadway Federal Bank Receives Bank Enterprise Award from U.S. Treasury’s CDFI Fund investment picks
American CareSource Holdings (NASDAQ: ANCI), a leading national network of ancillary health care providers and operator of urgent care centers, announced today that it has closed on a $5 million line of credit with a top-tier U.S. bank, giving the Company funding to continue its strategy of acquiring urgent care centers.
Sign-up for American CareSource Secures $5 Million Line of Credit investment picks
2014/8/11
Important New Variable Covered.
Sign-up for NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER investment picks
NEW YORK, July 30, 2014 (GLOBE NEWSWIRE) -- ForceField Energy Inc. ("ForceField") (Nasdaq:FNRG) , a designer, seller and distributor of energy products and solutions, today announced it had entered into a cross-marketing agreement with Branchburg, New Jersey based Noveda Technologies , a leader in cloud-based, real-time energy and water management systems; to deliver advanced solutions for energy and water efficiency to customers worldwide.
Sign-up for ForceField Energy and Noveda Technologies Sign Cross-Marketing Agreement to Provide LED Lighting and Energy Savings Solutions to Customers investment picks
2014/8/13
Regions Bank (NYSE: RF) today announced that Michele Byington is the August 2014 recipient of the Regions Bank Better Life Award.
Sign-up for Michele Byington, Orlando Private Wealth Advisor, Receives Regions Bank’s Top Associate Honor investment picks
Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, today announced dosing of the first patient in its Phase 2 clinical study of ETC-1002 in patients with hypercholesterolemia and hypertension, ETC-1002-014.
Sign-up for Esperion Therapeutics Announces Initiation of a Phase 2 Clinical Study of ETC-1002 in Patients with Hypercholesterolemia and Hypertension investment picks
ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash.
Sign-up for OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of a pre-specified secondary analysis of the Eliquis Phase 3 AMPLIFY-EXT trial (A pixaban after the initial M anagement of P u L monary embol I sm and deep vein thrombosis with F irst-line therap Y - EXT ended Treatment). The analysis evaluated clinical and demographic predictors of all-cause hospitalization in patients with VTE, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Results from this analysis demonstrated that during the 12-month extended treatment of VTE, Eliquis significantly reduced the risk of hospitalization versus placebo.
Sign-up for Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE) investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.
Sign-up for European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE investment picks
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for Eliquis for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy.
Sign-up for U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that they will present 14 abstracts (oral and poster presentations) at the ESC Congress 2014, organized by the European Society of Cardiology, to be held August 30 to September 4 in Barcelona, Spain.
Sign-up for Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014 investment picks
Potentially expanding its gastrointestinal-focused pipeline, RedHill has secured an option to acquire RP101 from Dresden-based RESprotect GmbH, a spin-off from the Fraunhofer-Society RP101 has completed several Phase I and Phase II clinical studies RP101 has been granted Orphan Drug designation for the adjunct treatment of pancreatic cancer by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) TEL-AVIV, Israel, Aug.
Sign-up for RedHill Biopharma Acquires Option for Phase II Pancreatic Cancer Drug RP101 investment picks
Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial agreement with Genentech to evaluate the safety, tolerability and preliminary efficacy of Incyte’s oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, in combination with Genentech’s PD-L1 immune checkpoint inhibitor, MPDL3280A, in patients with non-small cell lung cancer (NSCLC). Both INCB24360 and MPDL3280A are part of a new class of cancer treatments known as immunotherapies that are designed to enhance the body’s own defenses in fighting cancer; both agents target distinct regulatory components of the immune system.
Sign-up for Incyte Announces Clinical Trial Agreement to Evaluate Combination of Two Novel Cancer Immunotherapies investment picks
RESEARCH TRIANGLE PARK, N.C., Oct.
Sign-up for BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020982-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/3/11G020982/Metro_Link_by_WII-1127165357985.jpg FOREST CITY, IA--(Marketwired - September 03, 2014) - Winnebago Industries, Inc. (NYSE: WGO), a leading U.S. manufacturer of recreation vehicles, has announced a new Go Green initiative with the Company's Metro Link bus.
Sign-up for Metro Link by Winnebago Industries Includes Alternative Fuel Option in Partnership With ICOM North America investment picks
2014/8/28
On August 28, 2014, girls across the country are invited to step into the world of BeForever , American Girl’s line of historical dolls, books, and related accessories that connects girls ages 8 and up with inspiring characters and timeless stories from America’s past.
Sign-up for American Girl Unveils BeForever™ Line and Connects a New Generation of Girls to Timeless Stories, Inspiring Characters, and Endless Possibilities! investment picks
http://media.marketwire.com/attachments/201310/67151_SGI_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146840&ProfileId=051205&sourceType=1 MILPITAS, CA and TOKYO, JAPAN --
Sign-up for SGI Japan Delivers Large-Scale Shared-Memory Server to the Foundation for Promotion of Material Science and Technology of Japan investment picks
My Cloud™ EX2 / My Cloud™ EX4 and Smartvue Surveillance Software Provide the Surveillance Solution that Small Businesses and Prosumers Need IRVINE, Calif.
Sign-up for WD® And Smartvue Announce New Surveillance Platform Based On My Cloud™ EX Series investment picks
School Slashes VM Backup and Restore Times by 90% with vmPRO and DXi SAN JOSE, Calif.
Sign-up for Santa Barbara City College Turns To Quantum To Meet VM Protection Challenge investment picks
Cloudera, the leader in enterprise analytic data management powered by Apache TM Hadoop® , and Red Hat, Inc. (NYSE:RHT), the world’s leading provider of open source solutions, today announced an alliance to deliver joint enterprise software solutions including data integration and application development tools, and data platforms.
Sign-up for Cloudera and Red Hat Forge Big Data Alliance investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today said that Cowen / ATM, a leading venue neutral provider, announced the successful launch of CLEAN SEEK, the newest algorithm in the Cowen / ATM liquidity seeking suite of products.
Sign-up for Leading Venue Neutral Provider Cowen / ATM Helps Clients Navigate Today’s Complex Trading Environment investment picks
Microchip Technology Inc. (NASDAQ: MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced its latest Digitally Enhanced Power (DEPA) controllers—the MCP19118 and MCP19119 (MCP19118/9). They provide simple yet effective analog PWM control for DC-DC synchronous buck converters up to 40V, with the configurability of a digital MCU.
Sign-up for New Digitally Enhanced Power Analog Controllers from Microchip Offer Digital Power Supply Flexibility with Easy Analog Control Loops investment picks
2014/9/9
Citi cardmembers will soon have another way to pay with their Citi card at their fingertips with Apple Pay.
Sign-up for Citi to Integrate Credit and Debit Cards with Apple Pay investment picks
2014/9/9
U.S. Bank today announces its integration with Apple Pay, providing customers an easy, secure and private way to pay using their U.S. Bank consumer credit and debit cards right from iPhone 6, iPhone 6 Plus and Apple Watch.
Sign-up for U.S. Bank Provides Customers an Easy Way to Pay with Apple Pay investment picks
Integration with Apple Pay makes OpenTable payment experience even more intuitive and seamless SAN FRANCISCO , Sept 9, 2014 /PRNewswire/ -- OpenTable , the world's leading provider of online restaurant reservations and part of The Priceline Group (NASDAQ: PCLN) , today announced that it has integrated its "Pay with OpenTable" feature with Apple Pay and will introduce it to diners this fall.
Sign-up for OpenTable Integrates with Apple Pay to Enable Convenient Mobile Payments for Restaurant Goers investment picks
2014/9/11
Paying with mobile devices is about to become even more Priceless™. Today, Apple (NASDAQ:AAPL) unveiled Apple Pay that will enable MasterCard cardholders to use their iPhone 6, iPhone 6 Plus and Apple Watch for everyday purchases.
Sign-up for MasterCard Works with Apple to Integrate Apple Pay investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Manhattan Condo Inventory Shows Largest Annual Increase in Nearly Five Years, But Boost Doesn't Shake Record-High Sale Prices to MasterCard Works with Apple to Integrate Apple Pay
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices